BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 94 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $116,000 | +93.3% | 68,155 | +281.2% | 0.01% | +133.3% |
| Q1 2019 | $60,000 | -23.1% | 17,878 | -33.1% | 0.00% | -25.0% |
| Q4 2018 | $78,000 | -67.2% | 26,722 | -30.9% | 0.00% | -73.3% |
| Q3 2018 | $238,000 | +205.1% | 38,673 | +266.8% | 0.02% | +400.0% |
| Q2 2018 | $78,000 | -86.6% | 10,542 | -84.7% | 0.00% | -90.3% |
| Q4 2017 | $581,000 | +71.4% | 69,039 | +135.2% | 0.03% | +82.4% |
| Q3 2017 | $339,000 | – | 29,358 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |